Phase 1-2 Safety and Efficacy Study of DACOGEN in Sequential Administration With Cytarabine in Children With Relapsed or Refractory Acute Myeloid Leukemia
Phase of Trial: Phase I/II
Latest Information Update: 07 Feb 2018
At a glance
- Drugs Decitabine (Primary) ; Cytarabine
- Indications Acute myeloid leukaemia
- Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
- Sponsors Janssen Research & Development; Janssen-Cilag
- 31 Jan 2018 Status changed from suspended to completed.
- 25 Jan 2018 This trial has been completed in Netherlands.
- 19 Dec 2017 This trial has been completed in France